MannKind Corporation logo

MannKind Corporation

NASDAQ:MNKD

Overview | Financials
Company Name MannKind Corporation
Symbol MNKD
Currency USD
Price 5.59
Market Cap 1,541,599,020
Dividend Yield 0%
52-week-range 3.22 - 7.63
Industry Biotechnology
Sector Healthcare
CEO Dr. Michael E. Castagna Pharm.D.
Website https://www.mannkindcorp.com

An error occurred while fetching data.

About MannKind Corporation

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and

Related Stocks

Veru Inc. logo

Veru Inc.

VERU

0.56 USD

Crinetics Pharmaceuticals, Inc. logo

Crinetics Pharmaceuticals, Inc.

CRNX

40.4 USD

Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc.

LYEL

0.603 USD

Cassava Sciences, Inc. logo

Cassava Sciences, Inc.

SAVA

2.39 USD

NeoGenomics, Inc. logo

NeoGenomics, Inc.

NEO

13.95 USD

LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc.

LMAT

97.46 USD

Silk Road Medical, Inc logo

Silk Road Medical, Inc

SILK

27.49 USD

Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc.

AXSM

112.92 USD

Celularity Inc. logo

Celularity Inc.

CELU

1.99 USD

Financials

Numbers are in millions USD

Numbers are in millions USD